Gufic Biosciences Faces Rejection of NSE Penalty Waiver Application
Gufic Biosciences Ltd · Others (Uncategorized) · 24 Sept 2026, 8:55 pm
Gufic Biosciences Faces Rejection of NSE Penalty Waiver Application NSE has rejected Gufic Biosciences' waiver application regarding a penalty of ₹1,72,000 (excluding GST) levied for non-compliance with Regulation 17(1A) of SEBI LODR during the quarter ended Sep'24. The violation pertained to appointing an Independent Director aged above 75 years without prior shareholder approval via a special resolution. The company previously paid ₹8,000 each to BSE and NSE for Jun'24, while BSE rejected its waiver on 13th Mar'26. Gufic will pay the pending ₹1,72,000 fine to NSE by 3rd Oct'26.
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith · 17 Nov 2026
- Investor Presentation is attached herewith · 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. · 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith · 15 Nov 2026
- Outcome of the Board of Directors Meeting held on Saturday, November 14, 2026 is attached herewith. · 15 Nov 2026
- Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith · 13 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith · 16 Nov 2026
